Interaction of anthracyclines with covalently closed circular DNA.
D015250:Aclarubicin / Q000031:analogs & derivatives*; D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic; D001761:Bleomycin; D002360:Carubicin; D002499:Centrifugation, Density Gradient; D004270:DNA, Circular; D003630:Daunorubicin / Q000031:analogs & derivatives; D004058:Diffusion; D004317:Doxorubicin; D004347:Drug Interactions; D004587:Electrophoresis, Agar Gel; D008968:Molecular Conformation; D009279:Naphthacenes
D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic; D004270:DNA, Circular; D009279:Naphthacenes; C011157:aclacinomycins; D001761:Bleomycin; C015338:marcellomycin; D015250:Aclarubicin; D004317:Doxorubicin; D002360:Carubicin; D003630:Daunorubicin